US Stem Cell Inc (USRM)

[Dragon Lady]

10-Q, for first qtr 2014, should be out around 5/10/14 or there abouts, based on prior 10-Q releases.

First numbers I'll be looking for are cash on hand (balance sheet cash line entry), and new, total outstanding share count (dilution), usually on page 1, bottom of page. Should be able to determine then how many shares have been diluted/added since Dec. 31, 2013 10-K date.

Will then use search feature for name "ASHER" and look at any "financing" deals done since 10-K (will look for any names besides ASHER too; will just be looking for floorless, dilutive "financing")- to see what the terms were, for how much cash brought in, how steep a discount on shares, dilutive, if floorless convertible or not, etc

Will look for anymore "in the money" warrants potentially being issued and also if more "vesting ASAP" options have been granted- stuff like that.

Will then use search feature to look at "trials" and see if any update is given on MIRROR, or any other phase II/III trials for that matter.

Will also look for all past "deals" and "partnerships" or similar terms used in approx. 1 yr of past "PR" (middle east "deal" for example) and similar from the "PR's" to see if they are a) Are they even mentioned and b) What have they amounted to- any revenue from them, etc.

Then just read cover to cover to see if anything "new" pops out.

That's what I'll be looking for. Looking forward to it. Should be a good read IMO.